Your SlideShare is downloading. ×
  • Like
Theralase proven effective in the treatment of tobacco addiction oct 12 12
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.


Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Theralase proven effective in the treatment of tobacco addiction oct 12 12


laser acupunture,laser therapy,smoking addiction

laser acupunture,laser therapy,smoking addiction

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads


Total Views
On SlideShare
From Embeds
Number of Embeds



Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

    No notes for slide


  • 1. Press Release Theralase Effective in the Treatment of Tobacco AddictionToronto, Ontario – October 12, 2012 -- Theralase Technologies Inc. (TSX-V: TLT) announced today thatthe Theralase therapeutic laser system, has been proven clinically effective in the treatment of tobaccoaddiction.The Theralase technology was clinically evaluated on over 500 subjects, who were heavy smokers, tovalidate if they were able to reduce their smoking by at least 25%, 30 days after receiving the Theralaselaser treatment. The results of the clinical study demonstrated that 405 (73.8%) subjects had reducedtheir consumption of tobacco products by 25% or more, with 373 (92.0%) completely eliminating useand 32 of those subjects (8.0%) showing a reduction of at least 25%.Smoking is one of the most preventable illnesses that plague the American population. In 2009, theCenters for Disease Control and Prevention estimated that smoking accounted for $96 billion a year indirect health care costs and an additional $97 billion a year in lost productivity. Smoking addiction is acomplex condition, which can disrupt a person’s life, leading to severe health concerns, deteriorationof major organs, incurable diseases and eventually pre-mature death. In fact, more deaths are causedeach year by tobacco use than by all deaths from human immunodeficiency virus (HIV), illegal drug use,alcohol use, motor vehicle injuries, suicides and murders combined, with cigarette smoking causing 1out of every 5 deaths in the United States each year.Roger Dumoulin-White, President and CEO of Theralase stated that “Due to the complexity of smokingaddiction and the poor success rate that alternative cessation methods have had, this independentclinical study was commissioned to enroll 549 subjects, from a homogeneous, cosmopolitan populationof heavy smokers. The treatment group consisted of a relatively equal representation of male andfemale subjects with an average age in the mid to late forties. A Theralase therapeutic laser systemwas applied to specific ear and body acupuncture points to determine if the subject could reduce theirsmoking consumption by 25% or more 30 days after treatment. The results of the clinical studydemonstrated that at the 30 day follow-up end point, 405 (73.8%) subjects had met the outcomecriteria and had reduced their consumption of tobacco products by 25% or more, with 373 of thosesubjects (92.0%) completely eliminating use of tobacco products and 32 of those subjects (8.0%)showing a reduction of at least 25%. This non-pharmacologic and non-invasive therapeutic modalityexceeds the effectiveness of other therapeutic options currently available for smoking cessationtreatment, including nicotine patch, nicotine gum and other pharmaceutical alternatives.”Dr. Arkady Mandel, Chief Scientific Officer of Theralase said, “Due to the significant reduction in theconsumption of tobacco products by 405 (73.8%) subjects by 25% or more at the 30 day follow-up endpoint, the Theralase laser technology may find itself as a first line approach to combatting long termtobacco addiction in the not too distant future. Theralase laser acupuncture treatments may representa safe and effective alternative for reducing the amount of tobacco products consumed by smokers”.About Theralase Technologies Inc.:
  • 2. Press ReleaseTheralase Technologies Inc., founded in 1995, designs, develops, manufactures and markets patented,superpulsed laser technology utilized in biostimulation and biodestruction applications. Theralasetechnology is safe and effective in treating pain, inflammation and for tissue regeneration of neuralmuscular skeletal conditions and wound healing in both humans and animals. Theralase complies withall FDA, Health Canada, CE and international regulatory approvals to produce clinically effective, safeand high quality products. Theralase also develops patented Photo Dynamic Compound (PDC)technology focused at targeting and destroying cancers, bacteria and viruses when light activated byTheralase’s proprietary and patented laser technologies.For further information please visit, regulatory filings may be viewed by press release contains forward-looking statements, which reflect the Companys current expectations regarding future events. The forward-lookingstatements involve risks and uncertainties. Actual results could differ materially from those projected herein. The Company disclaims any obligation toupdate these forward-looking statements.Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchanges) acceptsresponsibility for the adequacy or accuracy of this release.For More Information, please contact:Roger Dumoulin - White,President and CEO416-447-8455 ext. 225rwhite@theralase.comKristina HacheyChief Financial Officer416-447-8455 ext. 224khachey@theralase.comGreg BewshDirector of Investor Relations416-447-8455 ext. 262gbewsh@theralase.comArkady MandelChief Scientific Officer416-447-8455 ext.